Covered recipient · General Payments record
LEYLA MIRBAHA
Eye and Vision Services Providers Optometrist
General Payments · PY2018–2024
$2,205.45
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $446.08 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $166.55 | 3 |
| ABBVIE INC. | $94.55 | 4 |
| Alcon Laboratories Inc | $54.50 | 2 |
| Oyster Point Pharma, Inc. | $40.92 | 2 |
| Mallinckrodt Hospital Products Inc. | $20.41 | 1 |
| Dompe US, Inc. | $19.70 | 1 |
| BIOTISSUE HOLDINGS INC. | $17.72 | 1 |
| RxSight Inc | $16.88 | 1 |
| Thea Pharma Inc. | $14.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.07 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105043874 | CMS |
| ABBVIE INC. | $14.89 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105043876 | CMS |
| ABBVIE INC. | $25.44 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105043878 | CMS |
| ABBVIE INC. | $29.15 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105043880 | CMS |
| Alcon Vision LLC | $24.44 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110684622 | CMS |
| Alcon Vision LLC | $30.06 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110684624 | CMS |
| Astellas Pharma US Inc | $109.98 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139425419 | CMS |
| Astellas Pharma US Inc | $22.39 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139425045 | CMS |
| Astellas Pharma US Inc | $34.18 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139438770 | CMS |
| BIOTISSUE HOLDINGS INC. | $17.72 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148763592 | CMS |
| Dompe US, Inc. | $19.70 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151409527 | CMS |
| Mallinckrodt Hospital Products Inc. | $20.41 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145108471 | CMS |
| Oyster Point Pharma, Inc. | $22.97 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147429127 | CMS |
| Oyster Point Pharma, Inc. | $17.95 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147430711 | CMS |
| RxSight Inc | $16.88 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144222242 | CMS |
| Thea Pharma Inc. | $14.85 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074543247 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.